We are excited to be collaborating once more with the excellent scientists at Johns Hopkins University ... Having this microRNA-based test assessed for clinical validity by faculty at one of the country's top cancer research centers is viewed by us as a strong indication to the interest this product and our technology are generating in the oncology world.
















